Inherited Disorders of Haemostasis and Thrombosis Dr Cleona Duggan Consultant Haematologist.

Slides:



Advertisements
Similar presentations
The Basics of Hemophilia
Advertisements

HEMOPHILIA By: Jess Gardner and Claire Griffin.
Initiation substances activate s by proteolysis a cascade of circulating precursor proteins which leads to the generation of thrombin which in turn converts.
The Basics of Hemophilia Nursing Working Group National Hemophilia Foundation.
Bachelor of Chinese Medicine, The University of Hong Kong Bleeding disorders Dr. Edmond S. K. Ma Division of Haematology Department of Pathology The University.
Coagulation Disorders
Haemostasis Tiffany Shaw MBChB II Haemostasis Pathway Injury Collagen exposure Tissue Factor Platelet adhesion Coagulation Cascade Release reaction.
HAEMATOLOGY MODULE: COAGULATION DISORDERS 1 Adult Medical-Surgical Nursing.
Anatomy and Physiology 3/15 and 3/16
Gatmaitan, Raymond Vincent Golpeo, Kirsten C.
MLAB 1227: Coagulation Keri Brophy-Martinez
An Introduction to Haemophilia and related bleeding disorders M QARI, MD, FRCPA.
An Introduction to Haemophilia and related bleeding disorders
MISHA MAZHAR 2k10-NUST-BS-V&I-54.  Mutations in F8 or F9 genes.  Leads to lack of proteins made by these genes.  F8 responsible for making the blood.
Lecture NO- 12- Dr: Dalia Kamal Eldien.  Coagulation: Is the process by which blood changes from a liquid to a clot. Coagulation begins after an injury.
Blood disorders.
Tabuk University Faculty of Applied Medical Sciences Department Of Medical Lab. Technology 3 rd Year – Level 5 – AY
Hemophilia A By Marissa Miuccio.
Bleeding Disorders Dr. Farjah H.AlGahtani
Sarah Moreno Ms.Brown Child dev. -6
VON WILLEBRAND DISEASE Nairobi, Kenya June 25, 2013.
Approach to Bleeding Disorders
APPROACH TO BLEEDING DISORDERS. History of Bleeding Spontaneous vs. trauma/surgery-induced Ecchymoses without known trauma Medications or nutritional.
Child with hematological dysfunction Emad Al Khatib, RN,MSN,CNS.
Coagulation Concepts A review of hemostasis Answers are in the notes pages.
Haemostasis Presented by Dr Azza Serry. Learning Objectives  Definition.  Clotting mechanism.  What keeps blood in fluid status  Control of blood.
The hemophilias A and B X-linked hereditary blood clotting disorders due to deficiency of factor VIII (hemophilia A) or factor IX (hemophilia B) Identical.
Factor II Deficiency By Jessica Johnson Medical Terminology II December 2, 2004.
Hemophilia Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, MASA What is: Hemophilia is an X-linked congenital bleeding disorder.
Hemophilia  Definition: rare bleeding disorders due to inherited deficiencies in co-agulation factors  Types: 1. Haemophilia A (Classic) Factor VIII.
SCREENING COAGULATION STUDIES When & when NOT to do them.
Objectives At the end of this lecture student should be able to: 1.Recognize different stages of hemostasis 2.Describe formation and development.
Investigation of Haemostasis MS. c. program Lab-9.
Genetics Hemophilia Presentation By Will Mcauliffe-Trefz-Genetics.
Bleeding and Kristine Krafts, M.D. Thrombotic Disorders.
PLATELETS (PLTs) or Thrombocytes Dr. Taj Platelets Thrombocytes are Fragments of megakaryocytes in bone marrow.
The Basics of Hemophilia. Hemostatic System Blood vessels Platelets Plasma coagulation system Proteolytic or Fibrinolytic system.
Von Willebrand’s Disease. vWD Family of bleeding disorders Family of bleeding disorders Caused by a deficiency or an abnormality of von Willebrand Factor.
INHERITED DISORDERS OF COAGULATION von Willebrand Disease 1.
Intrinsic pathway Extrinsic pathway Common pathway The extrinsic pathway was required the addition of an exogenous trigger (originally provided by tissue.
1. Normal haemostasis Haemostasis is the process whereby haemorrhage following vascular injury is arrested. It depends on closely linked interaction.
Approach to the Bleeding Child. Evaluation  History Current Bleeding Medical Family  Physical exam  Selected laboratory investigations.
Hemophilia in Canis familiaris (dogs). General information MIM number: MIM number: MIA number: MIA number:
Coagulation tests CBC- complete blood count
Abnormal bleeding in children J Kiwanuka. GENERAL INTRODUCTION.
Chapter 23. Bleeding disorders associated with coagulopathy
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
Haemostasis describes the normal process of blood clotting. It takes place via a series of complex, tightly regulated interactions involving cellular.
Congenital bleeding disorders
Bleeding disorders Deficiency of any of the clotting factors leads to excessive bleeding Most common and important bleeding disorders are due Vitamin K.
Approach To Bleeding Disorders In Neonates
Hemophilia 2009.
HEMOPHELIA.
Coagulation cascade:.
General Principles of Hemostasis Kristine Krafts, M.D.
Diagnosis Approach of Bleeding in Children ________________________________ Ketut Ariawati Hematologi Onkologi RSUP Sanglah Denpasar.
Constituents of the blood: Platelets and plasma
Hemophilia.
Dr-Majid Qanavat Ped. Hematologist oncologist Isfahan university -1396
Intrinsic pathway Formation of prothombin activator is the central event in the clotting pathway For its formation the pathway that is initiated by.
Bleeding and Thrombotic Disorders Kristine Krafts, M.D.
Hemophilia By: Renee Marie Alta.
General Principles of Hemostasis Kristine Krafts, M.D.
The child with hematological dysfunction
Dr. Festus Njuguna Moi University/MTRH
Hemostasis Hemostasis depends on the integrity of Blood vessels
Dr. Ahmed Hassaneen Coagulation disorders.
Hemostasis and Coagulation
Presentation transcript:

Inherited Disorders of Haemostasis and Thrombosis Dr Cleona Duggan Consultant Haematologist

How does bleeding start and stop? Blood vessel injury The capillary contracts to help slow the bleeding. Platelets make a plug to patch the hole. Clotting factors in plasma work together to form a clot over the plug.

How does bleeding start and stop? Blood vessel injury The capillary contracts to help slow the bleeding. Platelets make a plug to patch the hole. Clotting factors in plasma work together to form a clot over the plug.

Prolonged bleeding in Haemophilia Haemophilia - clotting factor absent or low. This makes it difficult for the blood to form a clot, so bleeding continues longer than usual (not faster). FVIII deficiency FIX deficiency

Vessel injury Platelet Release rxn Platelet Aggregation Vasoconstriction Coagulation Cascade Stable Haemostatic Plug

Congenital bleeding disorders Haemophilia A (Factor VIII Deficiency) Haemophilia B (Factor IX Deficiency) Von Willebrand Disease Factor X Deficiency Factor XI Deficiency Factor VII Deficiency Factor V Deficiency Congenital thrombocytopenia Platelet function defect Rare defects

Principal Bleeding Disorders Haemophilia A (factor VIII deficiency) Haemophilia B (factor IX deficiency) von Willebrand Disease (vWD) Other

Haemophilia Haemophilia A VIII deficiency X-linked, 1/3rd carriers <50% FVIIIC. 1:20,000 births Haemophilia B IX deficiency X-linked, 1/3rd carriers <50% FIXC. 1:100,000 These are clinically indistinguishable

Haemophilia 1:10,000 males FVIII > FIX x 6 X-linked recessive -lyonisation- females can be affected. 1/3 no family history / spontaneous mutation in FVIII/FIX genes of mother. Molecular diagnosis possible > 90% Carrier status of mother can be accurately predicted (though germline mosaicism cannot be excluded even if maternal DNA does not appear to carry the mutation)

Inheritance What are the chances a baby will have haemophilia? Females XX MalesX Y. The haemophilia gene is carried on the X chromosome X-LINKED DISORDER

INHERITANCE OF HAEMOPHILIA

Haemophilia Spectrum of severity is wide - clinical phenotype tends to be similar in all affected members of the same family When there is no family history, infants with moderate/severe disease usually present: – post-circumcision bleeding – bad “toddler bruising” – soft tissue/muscle or joint bleeds at 6-18 months of age – RARE, intracranial, ilio-psoas, intra-abdominal, haematuria

DISEASE SEVERITY % 5-50% 2-5% <1% Mild Moderate Severe

Detection of Haemophilia Family history Symptoms Haemostatic challenges – Surgery – Dental work – Trauma, accidents Laboratory testing APTT prolonged in FVIII/FIX deficiency F VIII, F IX,vWF

Ankle bleed

Bleeding following a vein puncture using a vacuum system

Femoral arterial puncture

Haemophilia in pregnancy  Delivery & neonatal period is a high risk time for baby and carrier mother  In 1/3 of cases there is no family history  31% of carriers with +ve family history not aware of their carrier status at delivery*  Knowledge of carrier status has an impact on delivery and management of baby Mothers unaware of their status were more likely to have instrumental deliveries* *Maclean Haemophilia 2004; 10: 560-4

CLINICAL PRESENTATION Bleeding has a prediliction for joints, particularly weight bearing. – Haemarthrosis – Also bleed intramuscularly – Bleed post haemostatic challenge – surgery/dental extraction/injury – Intracranial haemorrhage

HAEMOPHILIA - HAEMARTHROSIS

CHRONIC JOINT BLEEDING

Which joint bleeds are most common? Most common ankles, knees, and elbows – weight bearing joints Bleeds in other joints can also happen, including the toes, shoulders, and hips.

What happens in a joint bleed? joint feels tingly and warm. Swelling, painful and difficult to move.

Long-term effects of Joint bleeds? Repeated bleeding causes synovium (lining) to swell The synovium stops producing the slippery, oily fluid that helps the joint move. Damages the cartilage- joint stiff, painful and unstable. With time, most of the cartilage breaks down and some bone wears away. The whole process is called haemophilic arthropathy.

What Happens in a Muscle bleed? During a bleed, the muscle feels STIFF and PAINFUL. The bleed causes SWELLING that is WARM and PAINFUL to touch. In some deeper muscles, the swelling may press on nerves or arteries, causing TINGLING and NUMBNESS muscle SPASM.

Common Muscle Bleeds Calf, thigh, and upper arm. Bleeds in the psoas muscle (front of the hip Can put pressure on nerves and arteries, causing permanent damage. (numbness – classic sign) Joints above and below the muscle can’t move properly. May bleed more often. Nerve damage.

Serious or Life-threatening bleeds? Head injury - Throat /airway bleeds Major loss uncommon except after injury or if related to another medical condition. Other bleeds may be very serious, but usually not life-threatening, eg bleeds into the eyes, spine, and psoas muscle.

Haemophilia Mild haemophilia ( %): –bleed only with trauma and surgery. Severe haemophilia( < 1%) : –Haemarthroses 2-8 times/month. –Muscle bleeds. –Intracerebral bleeding –Prolonged bleeding with trauma and surgery.

Treatment of Bleeds Bleeds should be treated quickly to recover more fully, quickly and prevent later damage. If in doubt, treat. Don’t wait!

Treatment of bleeding disorders - general principles Avoid IM injections Avoid NSAIDs Avoid delay in treating the patient. Treat on suspicion of a bleed Listen to the patient - he/she has lifelong experience Record any treatment given including batch numbers to ensure full traceability of factor concentrates Contact the haematologist on call if in doubt

Evolution of Clotting Factor Therapy 1. Fresh whole blood 2. Fresh frozen plasma ( FFP ) 3. Cryoprecipitate ( “CRYO” ) 4. Factor VIII / IX concentrates 5. Ultra high purity plasma derived factor VIII / IX concentrates 6. Recombinant factor concentrates

Factor Concentrates CONCENTRATEINDICATION HALF - LIFE Advate Recombinant FVIII Deficiency 12 Hours BeneFIXRecombinant FIX Deficiency 18 Hours NovosevenRecombinant Patients with inhibitors to FVIII or FIX +/-2.7 Hours

Role of factor concentrate Replaces missing factor Injected IV Bleeding stops when enough factor reaches the bleeding site Treat ASAP R.I.C.E.

Investigation of bleeding disorders PT, APTT Von Willebrand Factor Specific clotting factor assays Platelet function testing

Von Willebrand Disease yr old girl – died at 13yr during 4 th menstrual period 5yr old girl – died at 13yr during 4 th menstrual period 4 siblings died from gastrointestinal haemorrhage 4 siblings died from gastrointestinal haemorrhage Both parents had significant bleeding history Both parents had significant bleeding history VWF – identified 1950s, purified 1972, sequenced 1985 VWF – identified 1950s, purified 1972, sequenced 1985

Von Willebrand Disease Up to 1% of the population 125 / million have a clinically significant bleeding disorder Autosomal inheritance

Von Willebrand factor Large glycoprotein produced by endothelial cells and megakaryocytes Mediates platelet to endothelial adhesion Mediates platelet to platelet interaction Carrier protein for Factor VIII

Von Willebrand Disease MILD/MODERATE BLEEDING TENDANCY mucocutaneous bleeding easy bruising epistaxis menorrhagia recurrent iron deficiency family history

VWD Treatment Avoid NSAIDs Avoid IM injections Vaccinate against Hepatitis A and B Treat anaemia Dental hygiene Very few patients require treatment with clotting factor concentrate

VWD TREATMENT -Specific measures Fandhi –plasma derived product DDAVP Cyclokapron

DDAVP Promotes release of VWF and factor VIII from endothelial cells 0.3ug/kg in 100mls N/Saline over 30 mins Average response is a threefold rise in VWF and FVIII Treatment of choice in responsive patients for spontaneous bleeding, trauma or minor surgery Intra nasal DDAVP

VWD TREATMENT -Specific measures Cyclokapron – Antifibrinolytic agent – Stabilises clot – Given orally – Provides adequate cover for minor procedures or dental work

Recognition of Bleeding Disorders

The Bleeding History Personal history – Epistaxis – Bleeding post surgery – Bleeding post dental extraction – Menorrhagia – History of anaemia – Easy bruising Family history NB

The Bleeding history Coag. Deficiencies Prolonged bleeding after trauma and surgery (>24 hrs). Haemarthroses Muscle bleeding. Platelet defects and VWD: Bruising. Petechiae or purpura. Epistaxis. Menorrhagia Prolonged post- trauma bleeding

Investigations

TISSUE FACTOR +TF VII TISSUE FACTOR COMPLEX XI IX X VIII V PROTHROMBIN THROMBIN VIIVIIa FIBRINOGEN Va VIIIa XIa IXa Xa TRIGGER FIBRIN

Investigation of bleeding disorders FBC - platelet count Prothrombin time (PT) - factors V, VII, X Activated partial thromboplastin time (APTT)- factors VIII, IX, XI, XII Fibrinogen

Tissue Damage Tissue Factor Exposure / Thromboplastin FVIIFVIIa FX FXa IIIIa FibrinogenFibrin Fibrin Polymer Fibrin Clot FVFVa Tissue factor (Extrinsic) Pathway IIa

KallikreinPrekallikrein FXII FXIIa FXI FXIa FIX FIXa FX FXa IIIIa FibrinogenFibrin Fibrin Polymer Fibrin Clot FVIIIFVIIIa FVFVa Contact factor (Intrinsic) Pathway IIa

VWD diagnosis Coag screen often normal VWF - quantiative assays VWF Ricof - functional assay

VWD - diagnosis Levels increased by menstrual cycle, OCP, pregnancy, smoking, stress, inflammatory disorders Repeat sampling recommended equivocal results minor abnormalities strong personal or family history